✦ LIBER ✦

Concurrent chemoradiotherapy and adjuvant chemotherapy with Topotecan for patients with glioblastoma multiforme

✍ Scribed by G. Klautke; M. Schütze; I. Bombor; R. Benecke; J. Piek; R. Fietkau

Publisher: Springer US
Year: 2005
Tongue: English
Weight: 192 KB
Volume: 77
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-005-9028-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin and teniposide concurrent wi

Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme : A Phase II Study

✍ Alba A. Brandes; Alberto Rigon; Paolo Zampieri; Mario Ermani; Carla Carollo; Giu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## BACKGROUND. The outcome after treatment for glioblastoma remains poor

Salvage chemotherapy with cyclophosphami

Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme

✍ Marc C. Chamberlain; Denice D. Tsao-Wei 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

## Abstract ## BACKGROUND The primary objective of the current prospective Phase II study of cyclophosphamide (CYC) in adult patients with recurrent, temozolomide‐refractory glioblastoma multiforme was to evaluate 6‐month progression‐free survival (PFS). ## METHODS Forty patients (28 men and 12

Concurrent chemoradiotherapy for esophag

Concurrent chemoradiotherapy for esophageal carcinoma patients with malignant fistulae

✍ Manabu Muto; Atsushi Ohtsu; Shin-ichi Miyamoto; Kei Muro; Narikazu Boku; Satoshi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## BACKGROUND. It remains controversial whether chemotherapy and/or radiotherapy are/is contraindicated for esophageal carcinoma patients with malignant fistulae. In some case reports, closure of fistulae by chemotherapy or radiotherapy has been reported. The current study investigated chemoradioth

Can we afford to add chemotherapy to rad

Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death

✍ Jean-Blaise Wasserfallen; Sandrine Ostermann; Alessia Pica; René-Olivier Miriman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

A Phase II trial of paclitaxel and topot

A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma

✍ J. Marc Pipas; Louise P. Meyer; C. Harker Rhodes; Laurence D. Cromwell; Carol E. 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 286 KB

Adjuvant chemotherapy with carmustine an

Adjuvant chemotherapy with carmustine and cisplatin for patients with malignant gliomas

✍ W. K. Alfred Yung; Todd J. Janus; Moshe Maor; Lynn G. Feun 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 339 KB

Forty-five patients with malignant gliomas were treated after aggressive surgical resection with alternating intravenous carmustine and cisplatin both during and after radiation therapy. Thirty-three patients were considered evaluable for responses, 17 had glioblastoma multiforme (GBM), 14 had anapl